Header cover image

U.S. Biotech Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies643
  • 7D0.4%
  • 3M-9.8%
  • 1Y5.3%
  • YTD1.5%

Over the last 7 days, the Biotech industry has remained flat, although notably Moderna gained 25%. The past year has been better, since the industry has gained 5.3% in that time.

Industry Valuation and Performance

Has the U.S. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021US$1.5tUS$211.9bUS$3.2b25x
Tue, 26 Oct 2021US$1.5tUS$196.3b-US$2,796,498,972.0024x
Thu, 23 Sep 2021US$1.6tUS$196.3b-US$2,199,783,766.0025.1x
Sat, 21 Aug 2021US$1.5tUS$197.0b-US$1,662,914,785.5822.1x
Sat, 05 Jun 2021US$1.4tUS$174.8b-US$11,505,542,875.5522.2x
Tue, 09 Mar 2021US$1.4tUS$162.7b-US$11,496,166,604.2118.1x
Mon, 30 Nov 2020US$1.3tUS$150.4b-US$5,042,974,751.8819.6x
Thu, 03 Sep 2020US$1.1tUS$138.5b-US$5,449,291,374.2921.9x
Sun, 07 Jun 2020US$900.8bUS$100.1b-US$4,920,056,632.4217.6x
Sat, 29 Feb 2020US$753.5bUS$98.4b-US$941,764,614.9715.1x
Tue, 03 Dec 2019US$757.8bUS$96.7b-US$2,815,023,937.8510.8x
Fri, 06 Sep 2019US$642.7bUS$94.3bUS$1.3b15.5x
Mon, 10 Jun 2019US$604.5bUS$93.1bUS$2.6b13.4x
Sun, 03 Mar 2019US$688.2bUS$89.5bUS$2.2b17.7x
Wed, 05 Dec 2018US$671.6bUS$88.9b-US$10,304,107,868.9621.4x
PE Ratio

21.4x

Total Market Cap: US$671.6bTotal Earnings: -US$10,304,107,868.96Total Revenue: US$88.9b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 25.0x which is higher than its 3-year average PE of 18.1x. It appears they are confident that earnings will grow faster in the future than they have historically.

Past Earnings Growth: Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 34% per year. This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Biotech industry?

Biotech0.45%

Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 18.1x. However analysts expect its future annual earnings growth (9.9%) to be largely in line with prior year's earnings growth, so the market might believe analysts are underestimating its future growth since investors are willing to pay a bigger premium today.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 9.9% over the next 5 years. This is roughly in line with its past earnings growth rate.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
MRNA Moderna25.0%+US$26.7b159.5%PE18.9x
BNTX BioNTech20.1%+US$14.1b216.4%PE9.9x
GILD Gilead Sciences2.3%+US$2.0b17.1%PE11.9x
NVAX Novavax13.3%+US$1.9b73.4%PS13.7x
ALNY Alnylam Pharmaceuticals4.2%+US$900.6m45.2%PS30.1x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BNTX

US$348.00

BioNTech

7D

20.1%

1Y

216.4%

NVAX

US$217.97

Novavax

7D

13.3%

1Y

73.4%

MRNA

US$329.63

Moderna

7D

25.0%

1Y

159.5%

AMGN

US$201.09

Amgen

7D

-2.4%

1Y

-10.6%

INCY

US$68.38

Incyte

7D

6.0%

1Y

-17.9%